700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02641

Synthetic patientMETA-24 · Day 170 · 25–34 · F · baseline S05Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
33%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S05
  2. Day 15 Trajectory diverged from prediction — Observed response fell below the model's expected path.
  3. Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
  4. Day 23 Patient accepted — Started DT-01 in the companion
  5. Day 28 No meaningful change — Dosing / Timing Recommendation DT-01

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • Inflammatory activity+16
  • Nutritional resilience-11
  • GI instability+10
  • Treatment adherence-10
  • Toxicity+7

What helped?

  • Dosing / Timing Recommendation DT-01Day 22
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
94 min
stable · -2.4 vs previous 14 d
Sleep duration
Wearable
5.5 h
improving · +0.3 vs previous 14 d
Energy level
Daily log
5.5/10
stable · -0.1 vs previous 14 d
Steps
Wearable
9,828
worsening · -389 vs previous 14 d
GI burden
Companion
24.3/100
worsening · +1.5 vs previous 14 d
Adherence
Companion
85.1 %
worsening · -5.8 vs previous 14 d
Sleep quality
Wearable
31.5/100
stable · +1.1 vs previous 14 d
Glucose, CGM daily mean
CGM
142 mg/dL
stable · -2.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 59 from the failing basin, 36 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -5.4 next day on high-intake days · n 24
Would not help
  • DT-01 Dosing / Timing Recommendation
    already tried, no meaningful change
  • BR-03 Behavioural Recommendation
    only 13% improved among 8 similar
  • Keep ultra-processed low
    GI +5.2 next day on high-intake days · n 26
  • Keep fat low
    GI +4.5 next day on high-intake days · n 20
  • Keep simple carbs low
    GI +3.2 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.4supporter · 95%
  • Ultra-processed food
    +5.2detractor · 95%
  • Dietary fat load
    +4.5detractor · 95%
  • Simple carbohydrates
    +3.2detractor · 87%
  • Alcohol
    -1.4no signal · 31%
  • Insoluble fibre
    +1no signal · 20%
  • Caffeine
    -0.6no signal · 15%
  • Histamine load
    +0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production ↓60
    • MicrobiomeButyrate capacity 40/100
    • MicrobiomeF. prausnitzii depleted
  • Autonomic recovery ↓45
    • WearableResting HR 77 bpm
    • WearableShort sleep window
  • Mucosal barrier integrity ↓40
    • MicrobiomeAkkermansia low → thinner mucus layer
    • WearableSleep 5.5 h, below personal baseline
  • Inflammatory signalling ↑25
    • DNAIL6 -174 variant raises baseline inflammatory tone
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Intermediate metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.8 · butyrate capacity 40/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
65 ms
Sleep
6.0 h
Steps
9,293
Resting HR
76 bpm
Daily log: GI score 24, nutritional resilience 62, adherence 85.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0208736%S01BR-03no change40
P-0243736%S01——64
P-0252236%S01BR-03no change40
P-0268136%S01——51
P-0221835%S01DT-01improved61
P-0221733%S01——61
P-0227632%S01——57
P-0242432%S01——62
P-0243832%S01——32
P-0256832%S01——51
P-0259832%S01——53
P-0262032%S01HY-01improved64